Innovent Biologics, Inc. IVBXF
11.31 USD +1.24 (+12.31%)
At closeNov 4, 2026, 4:00 PM EST
10.35 Day range 10.35
9.10 52-week range 15.01
- YTD
- +16.00%
- 1 year
- +6.20%
- Market cap
- 19.72B
- EPS (ttm)
- 0.10
- P/E ratio
- 113.10
- YTD return
- +16.00%
- 1-year return
- +6.20%
- Volume
- 500
- Avg volume
- 1.94K
- Open
- 10.35
- Previous close
- 10.07
- Day's range
- 10.35 – 10.35
- 52-week range
- 9.10 – 15.01
- Earnings date
- Aug 26, 2026
1D +1.24 (+12.31%)
Next earnings
Aug 26, 2026
Expected Aug 26, 2026. Consensus EPS estimate 0.06917.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 26, 2026 | Jun 30, 2026 | 0.06917 | — | — | — |
| Mar 26, 2026 | Dec 31, 2025 | 0.01716 | -0.00143 | -0.02 | -108.33% |
| Aug 27, 2025 | Jun 30, 2025 | 0.02512 | 0.06865 | +0.04 | +173.29% |
| Mar 26, 2025 | Dec 31, 2024 | -0.0315 | 0.02501 | +0.06 | +179.40% |
| Aug 28, 2024 | Jun 30, 2024 | -0.03439 | -0.03329 | 0.00 | +3.20% |
| Mar 20, 2024 | Dec 31, 2023 | -0.07042 | -0.07922 | -0.01 | -12.50% |
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on IVBXF — it syncs with the Stock Master app.